Gregory Gubitz

Through his years of travels, Greg has developed a deep passion for conservation and the preservation of Africa’s wildlife and wildlands. In 2011, after seeing the devastation caused by massive amounts of poaching in Kenya, he became involved in the creation of Big Life Foundation Canada and has been actively involved with Big Life since then. In 2020, he became Chair of Big Life Foundation USA.

Professionally Greg is a seasoned CEO and business lawyer. He was the co- founder and is currently the Chairman of HLS Therapeutics a pharmaceutical company providing critical medicines across Canada and the United States. He led HLS from start-up, to a publicly traded company, and Big Life now benefits from these same leadership skills.

Mr. Gubitz was Senior Vice President, Corporate Development and General Counsel of Biovail Corporation, formerly Canada’s largest publicly traded pharmaceutical company. In that capacity, he was responsible for mergers & acquisitions and product acquisitions, culminating with the $7 billion merger of Biovail and Valeant Pharmaceutical International Inc.  

Before joining Biovail, for 10 years, he was a senior executive with MDS Capital, a leading North American venture capital company, focused on healthcare. As Chief Operating Officer of MDS Capital, Mr Gubitz was responsible for all operational aspects of the company with a total of $1 billion under management. 

Greg started his career practicing law and became a partner at one of Canada’s leading international law firms, where he represented numerous public and private companies in a wide range of transactions.